United States: 957 Salts Too Many To "At Once Envisage"; Mylan's Attacks On Patentability Peter Out - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

In Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp., No. 21-2121 (Fed. Cir. Sept. 29, 2022), the Court of Appeals for the Federal Circuit ("the Federal Circuit") affirmed the Final Written Decision...